QGEN - QIAGEN N.V.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
1,516,125
1,501,848
1,417,536
1,337,991
1,280,986
Cost of Revenue
525,674
500,888
494,975
493,338
454,611
Gross Profit
990,451
1,000,960
922,561
844,653
826,375
Operating Expenses
Research Development
164,127
161,852
154,084
176,135
147,180
Selling General and Administrative
538,381
533,495
575,660
530,600
464,836
Total Operating Expenses
736,090
734,379
769,142
745,826
650,682
Operating Income or Loss
254,361
266,581
153,419
98,827
175,693
Interest Expense
76,047
67,293
49,685
39,022
37,396
Total Other Income/Expenses Net
-280,277
5,598
-4
-9,673
-10,552
Income Before Tax
220,918
225,737
114,375
56,908
132,498
Income Tax Expense
-52,845
35,357
73,981
-23,395
5,641
Income from Continuing Operations
-25,438
190,380
40,394
80,303
126,857
Net Income
-25,438
190,380
40,394
80,404
127,103
Net Income available to common shareholders
-25,438
190,380
40,394
80,404
127,103
Reported EPS
Basic
-
0.84
0.18
0.36
0.57
Diluted
-
0.82
0.17
0.35
0.56
Weighted average shares outstanding
Basic
-
226,640
226,557
225,873
224,376
Diluted
-
233,456
233,009
230,141
228,374
EBITDA
-
499,466
380,508
308,986
361,367